The privately held biotech company, founded in 2021 and based in San Mateo, California, specializes in using VLP platform technology to fast-track research in oncology and other diseases. Their engineered B-cell therapeutics offer a natural immune response and overcome limitations of current immunotherapies. Bespoke Biotherapeutics provides custom B-cell sourcing, activation, and genetic engineering methodologies to optimize commercial B-cell products for infusion. Their vision is to reprogram human B-cells into cellular immunotherapies that secrete specific proteins and antibodies to address serious illnesses and underserved populations.